Incyte Corp. buy marge
Start price
18.09.17
/
50%
€107.19
Target price
04.11.21
€135.30
Performance (%)
-45.48%
End price
05.11.21
€58.44
Summary
This prediction ended on 05.11.21 with a price of €58.44. The BUY prediction by marge for Incyte Corp. performed very badly with a performance of -45.48%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Incyte Corp. | 3.664% | 3.664% | -0.536% | -7.847% |
| iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
| iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
| iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
| iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by marge for this prediction
In the thread Incyte Corp. diskutieren
marge stimmt der Buy-Einschätzung von datca zu: siehe Beschreibung
marge stimmt am 17.11.2016 der Buy-Einschätzung von datca mit dem Kursziel 120$ zu.
Überschrift: Incyte Corporation (INCY),-Kooperationen mit Novartis,Eli Lilly,Merck,MedImmune,Bristol-Myers Squibb,Genentech,Pfizer
In the thread Trading Incyte Corp.
Die von marge gewählte maximale Laufzeit wurde überschritten